Ranbaxy recalls certain batches of Atorvastatin calcium tablets in US
Recall is limited to specific lots and strengths of generic cholesterol-lowering drug
Indian drugmaker Ranbaxy Laboratories has recalled its generic version of Pfizer’s cholesterol-lowering drug Lipitor in US, after certain batches of 10mg, 20mg, and 40mg doses of the drug, known generically as Atorvastatin calcium, were found to contain glass particles.
The 80mg strength is not affected, nor is any other Ranbaxy product in any other market, the company said.
Ranbaxy Pharmaceuticals Inc said it was recalling the drug product lots in the US ‘out of an abundance of caution’ and to protect customer safety.
The recall is being conducted with the full knowledge of the US FDA. The recall is limited to the US market only and affects specific lots numbers and strengths of this molecule manufactured by Ranbaxy, which are only for sale in the US.